1. Introduction {#sec0001}
===============

Coumarins (2H-chromen-2-ones) from natural sources are nontoxic and non-inhibitory against the biotransforming organism. These compounds have been identified in a large number of plants such as rutaceae, umbelliferae, legumes and orchids [@bib0001], [@bib0002], [@bib0003]. Many of the naturally and synthetic derivatives of coumarin have shown broad-spectrum of pharmacological, biological and physiological properties, including antibacterial, antifungal, antioxidant, anti-inflammatory, anti-allergic, antiviral, hepatoprotective, anti-tumor, anti-coagulant, anti-HIV and anti-carcinogenic agents [@bib0004], [@bib0005], [@bib0006], [@bib0007], [@bib0008], [@bib0009], [@bib0010], [@bib0011], [@bib0012]. Recently, this family of compounds has been used to prepare new drugs with very low toxicity [@bib0013], [@bib0014], especially for skin and autoimmune diseases [@bib0015].

4-hydroxycoumarins are important precursors in the preparation of antifungal, bacteriostatic, anti-coagulant, potentially anti-HIV, spasmolytic drugs and herbicidal agents. This category of products presents photochemical and photophysical characteristics and play a major role in modern optoelectronic [@bib0016], [@bib0017], [@bib0018], [@bib0019].

Coumarins-fused pyridine hybrids are the most important type of pharmaceutical intermediates, and are defined in the literature as potential anti-osteoporotic agents [@bib0020]. They have a high bio-compatibility due to the nitrogen atom that can form hydrogen bonds with biological molecules [@bib0021]. The complexes formed with coumarin-pyridine derivatives have attracted more attention from chemists because of their diverse structural design and scientific applications [@bib0022], [@bib0023], [@bib0024].

Since the listed positive effects of coumarin derivatives, we wondered if an alternative new synthetic molecule derived from coumarin might be designed to fight against infectious diseases caused by more virulent viruses. In perspective, this would prepare a drug against coronaviruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The coronavirus disease 2019 (COVID-19) causes severe respiratory infection and is known to be very contagious [@bib0025]. Currently, there are no treatments available for SARS-CoV-2, therefore, treatment is focused on symptoms which may include dry cough, fever and pneumonia [@bib0026].

According to the work of Lima de Oliveira et al., the identification of small molecules (ligands) which specifically target the sensitive sites of viruses plays a very important role in antiviral drugs discovery [@bib0027]. Herein we wish to report on our preliminary studies towards this objective.

In this work, the new 4-\[(*pyridin*-3-*ylmethyl*)*amino*\]−2*H*-chromen-2-one ligand (L~TA~) was synthesized and characterized by different techniques such as *single*-*crystal X-ray diffraction*, NMR, ATR, UV-Visible and cyclic voltammetry. Theoretical studies using DFT with B3LYP combined with the standard base set 6--31G+(d) were investigated to understand the chemical reactivity and the formation mechanism of L~TA~. The aim of this study is also to evaluate the mode of interaction of L~TA~ with SARS-CoV-2/Main protease (Mpro), whose inhibition of this enzyme would prevent the virus from replication.

2. Materials and methods {#sec0002}
========================

2.1. Apparatus and reagents {#sec0003}
---------------------------

Diffraction data were collected at 150 K on a D8 Venture Bruker AXS diffractometer equipped with a (CMOS) PHOTON 100 detector, Mo-*Kα* radiation (*λ* = 0.71073 Å, multilayer monochromator). Crystallographic data for the structural analysis have been deposited at the Cambridge Crystallographic Data Center, CCDC No 1981639. These data can be obtained via <https://www.ccdc.cam.ac.uk>, e-mail: deposit_reply\@ccdc.cam.ac.uk.

The attenuated total reflectance (ATR) spectrum was carried out on a BRUKER LPHA-T Spectrometer. All *nuclear magnetic resonance* measurements (^1^H NMR, ^13^C NMR and 2D-NMR) were performed at 25 °C with a Bruker Avance III Spectrometer.

The electronic spectra were recorded on a SECORD plus Spectrophotometer in the range 200--500 nm.

The electrochemical measurements were carried out using Potentiostat/Galvanostat Metrohm Autolab 302 N.

The theoretical calculations were performed using DFT/B3LYP/6--31G+ (d) level of theory.

All reagents and solvents used to prepare the measurement solutions were of the highest purity and analytical grade from Sigma--Aldrich or Fluka chemicals Company.

2.2. Synthesis of ligand {#sec0004}
------------------------

The ligand (4-\[(*pyridin*-3-*ylmethyl*)*amino*\]−2*H*-chromen-2-one: L~TA~) was synthesized by adding 1.08 mL of 3-picolylamine (10 mmol) to 10 mmol (1.62 g) of 4-hydroxycoumarin dissolved in 10 mL of absolute ethanol. The mixture was stirred under reflex at 70 °C for 48 h.

The bright incolor crystals of the product were grown by slow evaporation technique in ethanol for two weeks.

The obtained crystals are soluble in acetone, ethanol, water, dichloromethane (DCM), chloroform (CHCl~3~) and dimethylsulfoxide (DMSO).

Yield: 56% (1.405 g); m.p 198 °C. **^1^H NMR (400** **MHz, DMSO, 25** °**C, ppm, δ):** δ 4.59 (d, *J* = 5.9 Hz, 2 H13, C*H* ~2~); 5.17 (s, 1 H11, C*H*); 7.32 (dd, *J* = 8.3, 0.8 Hz, 1 H5, C*H*); 7.36 (dd, *J* = 10.5, 3.4 Hz, 1 H16~,~ C*H*); 7.38--7.41 (m, 1 H8, C*H*); 7.58--7.64 (m, 1 H6, C*H*); 7.76--7.82 (m, 1 H15, C*H*); 8.12 (dd, *J* = 8.1, 1.1 Hz, 1 H7, C*H*); 8.28--8.38 (m, 1 H12, *NH*); 8.49 (dd, *J* = 15.5, 4.2 Hz, 1 H17, C*H*); 8.60--8.76 (m, 1 H19, C*H*).

**^13^C NMR (101** **MHz, DMSO, 25** °**C, ppm, δ):** 43.60 (C13); 83.14 (C11); 114.87 (C9); 117.44 (C5); 122.94 (C7); 123.91 (C16); 124.08 (C8); 132.48 (C6); 133.76 (C14); 135.40 (C15); 148.91 (C17); 149.23 (C19); 153.50 (C4); 153.58 (C10); 161.85 (C2).

**HSQC---NMR (101** **MHz, DMSO, 25** °**C, ppm, δ):** 4.59:43.60 (H13:C13); 5.17:83.14 (H11:C11); 7.32:117.44 (H5:C5); 7.36:123.91 (H16:C16); 7.38:124.08 (H8:C8); 7.58:132.48 (H6:C6); 7.76:135.40 (H15:C15); 8.12:122.94 (H7:C7); 8.49:148.91 (H17:C17); 8.60:149.23 (H19:C19).

**HMBC---NMR (101** **MHz, DMSO, 25** °**C, ppm, δ):** 4.59:133.76:135.40:148.91:153.58 (H13: C14:C15 :C17 :C10); 5.17:114.87:161.85 (H11:C9 :C2); 7.32:114.87:124.08:153.50 (H5:C9:C8 :C4); 7.36:133.76 (H16:C14); 7.38 :132.48:153.58 (H8 :C6 :C10); 7.58:122.94:153.50 (H6 :C7:C4); 7.76:148.91:149.23 (H15:C17:C19); 8.12:132.48:153.58 (H7:C6 :C10); 8.28:83.14:114.87 (H12:C11:C9); 8.60:133.76:148.91 (H19:C14:C17).

[Scheme 1](#fig0011){ref-type="fig"} describes the synthesis mechanism of 4-\[(*pyridin*-3-*ylmethyl*) *amino*\]−2*H*-chromen-2-one. In solution, the likely tautomeric forms of 4-hydroxycoumarin are 2‑hydroxy‑4-chromenone (A) and 2, 4-chromandione (B) [@bib0028]. Indeed, synthesis of L~TA~ is carried out via nucleophilic attack of NH~2~ group of 3-picolylamine on the C10 carbonyl of 2, 4-chromandione with elimination of water molecule \[[@bib0029], [@bib0030]\], according to the following detailed mechanism:Scheme 1Synthesis mechanism of ligand (L~TA~).Scheme 1

3. Results and discussion {#sec0005}
=========================

3.1. Characterization of the ligand {#sec0006}
-----------------------------------

### 3.1.1. X-ray crystallography of L~TA~ {#sec0007}

Well defined colourless crystals, crystal size = 0.290 × 0.210 × 0.080 mm has been selected and mounted on a cryoloop for X-ray diffraction analysis. The crystal data of L~TA~ (C~15~H~12~N~2~O~2~: *M* = 252.27 g/mol) showed that the ligand crystallizes in monoclinic system with space group P2~1~. The crystallographic parameters are: *Z* = 4, *a* = 11.9894(17) Å, *b* = 7.3557(11) Å, *c* = 14.733(2) Å, α = 90°,β = 108.349(5)°, γ = 90°,*V* = 1233.3(3) Å^3^, μ(Mo-Kα) = 0.092 mm^−1^ and Dc = 1.359 g.cm^−3^. A total of 4244 reflections were collected. Final R~1~= 0.0858  \[*I* \> 2σ(I)\] and wR~2~ = 0.2373 (all data). Data completeness to theta 27.557°= 98.1%.

ORTEP representation of the product is shown in [Fig. 1](#fig0001){ref-type="fig"} a. All non-hydrogen atoms were refined with anisotropic displacement parameters.Fig. 1Structure of ligand: (a) ORTEP and (b) hydrogen bonds representation.Fig 1

There are two asymmetric-independent molecules of L~TA~ in the unit cell with a slight difference in the bond lengths and angles. The main difference between the two molecules arises primarily from 3-picolylamine group about the torsion angles N(12)--C(13)--C(14)--C(15) of structure 1 (−62.4°) and N(32)--C(33)--C(34)--C(35) of structure 2 (28.1°).

The crystal data, the conditions of data collection, isotropic and anisotropic displacement parameters, bond lengths (Å), bond angles (°) and torsion angles (°) are summarized in [Table 1](#tbl0001){ref-type="table"} , 2 and Tables S1, S2. There are three inequivalent hydrogen bonds in the crystal ([Fig. 1](#fig0001){ref-type="fig"}b and Table S3). The first and the second hydrogen bonds (N12-H12•••O21 and N32-H32•••O1) are short, their hydrogen bond distance are H12•••O21 = 1.99 Å and H32•••O1= 1.97 Å, respectively.Table 1Crystal data and structure refinement for L~TA~.Table 1Empirical formulaC~15~H~12~N~2~O~2~Formula weight (g/mol)252.27Temperature (K)150Wavelength (Å)0.71073Crystal systemMonoclinicSpace groupP 2~1~Unit cell dimensionsa, b, c (Å)*a* = 11.9894(17), *b* = 7.3557(11), *c* = 14.733(2)α, β, γ (°)alpha = 90, beta = 108.349(5), gamma = 90Volume (Å^3^)1233.3(3)Z4Calculated density (g.cm^−3^)1.359Absorption coefficient μ (mm^−1^)0.092F(000)528Crystal size (mm)0.290 × 0.210 × 0.080Crystal colorcolourlessTheta range for data collection (°)2.639 to 27.557h_min, h_max−15.14k_min, k_max0.9l_min, l_max0.19Reflections collected / unique4244/4244Reflections \[*I*\>2sigma(I)\]3351Completeness to theta_max0.981Absorption correction typemulti-scanMax. and min. transmission0.993, 0.974Refinement methodFull-matrix least-squares on F^2^Data/restraints/parameters4244/50/345Goodness-of-fit on F^2^1.346Final R indices \[*I*\>2sigma(I)\]R~1~ = 0.0858 ; wR~2~ = 0.2233R indices (all data)R~1~= 0.1190 ; wR~2~ = 0.2373Δ~ρ~ (min, max) \[e.*Å*^−3^\]0.376 ; −0.381

The third hydrogen bond, C39-H39•••N18 (not shown in [Fig. 1](#fig0001){ref-type="fig"}b) should be weaker because it corresponds a large distance H39•••N18 = 2.61 Å.

### 3.1.2. Geometry optimization of ligand {#sec0008}

In order to obtain stable structure, an optimization of the geometrical parameters of ligand L~TA~ has been carried out at DFT levels of theory [@bib0031] using the Becke\'s three parameter hybrid exchange functional in combination with Lee-Yang-Parr correlation functional (B3LYP) [@bib0032] at 6--31+*G*(d) basis sets. All calculations were obtained with the Gaussian09 program package [@bib0033].

The optimized parameters, namely, bond lengths and angles and Dihedral angles calculated by B3LYP/6--31+*G*(d,) and found by XRD are reported in [Table 2](#tbl0002){ref-type="table"}, according to the numbering atoms given in [Scheme 1](#fig0011){ref-type="fig"} and [Fig. 2](#fig0002){ref-type="fig"} . [Table 2a](#tbl0002){ref-type="table"} , [Table 2b](#tbl0003){ref-type="table"} , [Table 2c](#tbl0004){ref-type="table"} .Fig. 2Optimized geometry of ligand L~TA~: (a) L~TA(C1---C19)~ (Total energy (a.u):−838.80986151 and (b) L~TA(C21---C39)~ (Total energy (a.u):−838,80,986,137).Fig 2Table 2aBond lengths (Å) obtained by XRD and DFT/B3LYP/6--31 + *G*(d) for the ligand L~TA~.Table 2aAtomsDRXDFTAtomsDRXDFTStructure 1Structure 2O1 - C21.223(10)1.2129O21 - C221.218(10)1.2129C2 - O31.373(10)1.4041C22 - O231.384(11)1.4040C2 - C111.427(11)1.4409C22 - C311.419(11)1.4409O3 - C41.367(10)1.3603O23 - C241.373(10)1.3603C4 - C51.398(11)1.3998C24 - C291.396(11)1.4089C4 - C91.409(11)1.4089C24 - C251.397(12)1.3998C5 - C61.375(13)1.3896C25 - C261.383(13)1.3896C5 - H50.95001.0854C25 - H250.95001.0854C6 - C71.395(13)1.4028C26 - C271.379(13)1.4028C6 - H60.95001.0865C26 - H260.95001.0865C7 - C81.381(12)1.3899C27 - C281.376(12)1.3899C7 - H70.95001.0860C27 - H270.95001.0860C8 - C91.412(11)1.4094C28 - C291.417(11)1.4094C8 - H80.95001.0868C28 - H280.95001.0868C9 - C101.465(11)1.4658C29 - C301.468(11)1.4658C10 - N121.344(10)1.3712C30 - N321.336(10)1.3712C10 - C111.366(11)1.3729C30 - C311.376(11)1.3728C11 - H110.95001.0820C31 - H310.95001.0820N12 - C131.457(11)1.4563N32 - C331.451(11)1.4563N12 - H120.88001.0078N32 - H320.88001.0077C13 - C141.516(12)1.5222C33 - C341.524(12)1.5222C13 - H13A0.99001.0964C33 - H33A0.99001.0964C13 - H13B0.99001.0996C33 - H33B0.99001.0996C14 - C191.381(12)1.4012C34 - C351.382(13)1.3972C14 - C151.388(13)1.3972C34 - C391.384(12)1.4013C15 - C161.382(14)1.3948C35 - C361.372(14)1.3948C15 - H150.95001.0868C35- H350.95001.0868C16 - C171.371(14)1.3970C36 - C371.367(14)1.3970C16 - H160.95001.0864C36 - H360.95001.0864C17 - N181.347(15)1.3395C37 - N381.355(16)1.3395C17 - H170.95001.0882C37 - H370.95001.0882N18 - C191.347(13)1.3379N38 - C391.356(14)1.3379Table 2bBond angles (°) obtained by XRD and DFT/B3LYP/6--31 + *G*(d) for the ligand L~TA~.Table 2bAtomsDRXDFTAtomsDRXDFTStructure 1Structure 2O1 - C2 - O3115.9(8)116.88O21 - C22 - O23116.1(8)116.88O1 - C2 - C11125.3(8)126.61O21 - C22 - C31126.3(9)126.62O3 - C2 - C11118.8(8)116.50O23 - C22 - C31117.6(8)116.50C4 - O3 - C2120.6(6)122.06C24 - O23 - C22121.6(7)122.06O3 - C4 - C5115.6(8)116.28O23 - C24 - C29122.1(7)122.46O3 - C4 - C9122.2(7)122.46O23 - C24 - C25116.1(8)116.28C5 - C4 - C9122.3(8)121.26C29 - C24 - C25121.8(8)121.26C6 - C5 - C4119.1(9)119.67C26 - C25 - C24119.2(9)120.20C5 - C6 - C7120.2(9)120.20C27 - C26 - C25120.1(9)119.80C8 - C7 - C6120.9(9)119.80C28 - C27 - C26121.0(9)119.80C7 - C8 - C9120.7(9)121.28C27 - C28 - C29120.6(8)121.28C4 - C9 - C8116.9(8)117.78C24 - C29 - C28117.3(7)117.78C4 - C9 - C10118.3(8)117.30C24 - C29 - C30117.6(7)117.30C8 - C9 - C10124.8(8)124.92C28 - C29 - C30125.1(8)124.92N12 - C10 - C11123.8(8)122.70N32 - C30 - C31124.1(8)122.69N12 - C10 - C9119.1(8)118.58N32 - C30 - C29117.9(7)118.58C11 - C10 - C9117.1(7)118.72C31 - C30 - C29118.1(8)118.72C10 - C11 - C2123.1(8)122.93C30 - C31 - C22123.0(8)122.93C10 - N12 - C13123.9(8)123.84C30 - N32 - C33123.5(8)123.84C10 - N12 - H12118.1116.77C30 - N32 - H32118.3116.76C13 - N12 - H12118.1115.91C33 - N32 - H32118.3115.91N12 - C13 - C14114.3(8)114.81N32 - C33 - C34113.5(9)114.81C19 - C14 - C15118.0(9)117.39C35 - C34 - C39117.4(9)117.39C19 - C14 - C13120.2(9)119.76C35 - C34 - C33122.3(9)122.81C15 - C14 - C13121.7(8)122.81C39 - C34 - C33120.3(9)119.76C16 - C15 - C14119.0(9)119.054C36 - C35 - C34120.3(9)119.05C17 - C16 - C15118.7(11)118.67C37 - C36 - C35118.6(11)118.68C17 - C16 - H16120.7120.32C37 - C36 - H36120.7120.32C15 - C16 - H16120.7121.00C35 - C36 - H36120.7121.00N18 - C17 - C16124.0(10)123.21N38 - C37 - C36123.7(11)123.21C16 - C17 - H17117.9120.70C37 - N38 - C39116.2(10)117.35C17- N18 - C19116.0(9)117.35N38 - C39 - C34123.8(10)124.32Table 2cTorsion angles (°) obtained by XRD and DFT/B3LYP/6--31 + *G*(d) for the ligand L~TA~.Table 2cAtomsDRXDFTAtomsDRXDFTStructure 1Structure 2O1-C2-O3-C4−179.2(10)179.30O21-C22-O23-C24−179.4(10)−179.30C11-C2-O3-C40.1(14)−1.16C22-O23-C24-C290.6(15)−0.85C2-O3-C4-C5179.6(10)−179.10C22-O23-C24-C25179.9(10)179.09C2-O3-C4-C9−0.7(14)0.84O23-C24-C25-C26179.3(11)−179.51O3-C4-C5-C6179.0(10)179.51C24-C25-C26-C270.8(19)0.15C9-C4-C5-C6−0.7(16)−0.42C26-C27-C28-C291.3(18)−0.12C4-C5-C6-C71.5(17)−0.15O23-C24-C29-C28−178.9(10)179.12C6-C7-C8-C9−0.3(18)0.11C25-C24-C29-C281.8(15)−0.82O3-C4-C9-C8179.8(10)−179.12O23-C24-C29-C30−0.8(14)−0.64C5-C4-C9-C8−0.5(15)0.81C25-C24-C29-C30179.9(10)179.43O3-C4-C9-C100.6(14)0.64C27-C28-C29-C30−179.6(10)−179.60C5-C4-C9-C10−179.7(10)−179.43C24-C29-C30-N32−178.9(9)−179.20C7-C8-C9-C10−179.9(10)179.60C28-C29-C30-N32−1.0(14)1.06C4-C9-C10-N12−179.7(9)179.20C24-C29-C30-C311.3(13)1.75C8-C9-C10-N121.2(16)−1.05C28-C29-C30-C31179.2(10)−177.99C4-C9-C10-C110.1(14)−1.75N32-C30-C31-C22178.6(10)179.52C8-C9-C10-C11−179.1(10)178.00C29-C30-C31-C22−1.5(15)−1.47N12-C10-C11 - C2179.1(11)−179.53O21-C22-C3-C30179.8(11)−179.46C9-C10-C11-C2−0.7(15)1.46C31-C30-N32-C33−1.0(15)−8.97O1-C2-C11-C10179.9(12)179.47C29-C30-N32-C33179.2(9)172.02O3-C2-C11-C100.6(16)−0.03C30-N32-C33-C3477.7(12)79.70C11-C10-N12-C133.3(16)8.97N32-C33-C34-C3528.1(13)26.10C9-C10-N12-C13−176.9(9)−172.02N32-C33-C34-C39−154.1(9)−156.21C10-N12-C13-C14−79.0(12)−79.69C39-C34-C35-C362.3(16)−0.36N12-C13-C14-C19118.2(10)156.24C33-C34-C35-C36−179.8(10)177.38N12-C13-C14-C15−62.4(12)−26.07C34-C35-C36-C37−1.0(18)−0.26C19-C14-C15-C16−0.2(15)0.36C35-C36-C37-N38−1.0(2)0.52C13-C14-C15-C16−179.6(10)−177.38C36-C37-N38-C391.0(2)−0.10C14-C15-C16-C17−0.3(17)0.26C37-N38-C39-C340.5(18)−0.60C15-C16-C17-N180.3(19)−0.52C35-C34-C39-N38−2.1(16)0.84C16-C17-N18-C190.2(17)0.09C33-C34-C39-N38179.9(10)−176.98C17-N18-C19-C14−0.8(16)0.60C15-C14-C19-N180.8(15)−0.83C13-C14-C19-N18−179.8(10)176.98

The quantitative-chemical calculations of the two systems (L~TA(C1---C19)~) and L~TA(C21---C39)~) performed theoretically give similar results for bond lengths and angles, which are in agreement with the *X-ray diffraction data*. The slight differences found between the experimentally and theoretically calculated dihedral angles are due to the molecular interactions not taken into account by this chosen theoretical method, and to the effects of the solvent which have been neglected (gas phase).

However, the analysis of the total energy shows the same energy for:

L~TA(C1---C19)~ (−838.80986151 a.u) and L~TA(C21---C39)~ **(**−838.80986137 a.u) with a slight difference of around 10^−7^. For this, L~TA(C1---C19)~ structure was chosen for the rest of the theoretical study.

### 3.1.3. Spectroscopy and spectrophotometry studies {#sec0009}

The ATR spectrum was recorded to investigate the vibration modes of the functional groups and thus provide information on the structural dynamics of the ligand. In this study, the experimental spectrum of L~TA~ was superposed on that obtained theoretically ([Fig. 3](#fig0003){ref-type="fig"} ). The *assignments* of the various stretching and bending *vibrations* of the ligand were shown in Table S4.Fig. 3Vibrational spectra: (a) Experimental and (b) theoretical spectra of L~TA~.Fig 3

The functional groups present in L~TA~ correspond to the frequencies at which absorption are located. The characteristic vibration frequencies for the studied compound are given as follows:

In the experimental spectrum of L~TA~, N---H stretching vibration band is observed at 3286 cm^−1^ and its deformation vibration band is located at 1574 cm^−1^ **.** However, the theoretical spectrum showed N---H stretching and deformation vibrations at 3282 cm^−1^ and 1578 cm^−1^, respectively.

The symmetric and asymmetric C---H stretching vibrations of CH~2~ group can be found between 2850 and 3050 cm^−1^ \[[@bib0034], [@bib0035]\]. For this ligand, C---H stretching vibrations are observed theoretically and experimentally in the range 2900--3050 cm^−1^, and the deformation bands are found around 1468 cm^−1^ in both theoretically and experimental spectra. The other bands of C---H at 770--997 cm^−1^ are assigned to the out-of-plane deformation vibrations.

C---N stretching vibrations are located at 1350 cm^−1^, whereas these calculated with B3LYP program are given at 1335 cm^−1^.

In the ATR spectrum, *C* = *O* stretching modes are observed at 1672 cm^−1^ associated theoretically to the peak appeared at 1760 cm^−1^ [@bib0036]. However, the peaks found in the range 1270--1300 cm^−1^ and at 711 cm^−1^ are assigned to the stretching and deformation vibrations of the C---O groups, respectively.

NMR spectroscopy is one of the most powerful instruments for organic and inorganic structural identifications. The chemical shift *displacements* were calculated by the GIAO model (Gauge Including Atomic Orbital) \[[@bib0037], [@bib0038]\] in DMSO using the PCM model. Table 3Results of second-order perturbation calculations of the Fock matrix on a NBO basis corresponding to the intramolecular interaction of ligand L~TA~.Table 3Donor (i)TypeAcceptor (j)TypeE(2)(ξ~j~-ξ~i~)(F~i,\ j~)C~17~-- C~16~πC~15~ - C~14~π \*22.280.280.071πC~19~ - N~18~π \*18.160.260.062C~15~ - C~14~πC~17~ - C~16~π \*17.500.280.064πC~19~ - N~18~π \*27.140.270.076C~19~ - N~18~πC~17~ - C~16~π \*25.390.320.081πC~15~ - C~14~π \*13.800.320.060C~7~ - C~8~πC~9~ - C~4~π \*16.850.280.063πC~5~ - C~6~π \*19.630.290.067C~9~ - C~4~πC~7~ - C~8~π \*20.470.290.070πC~5~ - C~6~π \*15.740.290.062πC~10~ - C~11~π \*17.490.290.065C~5~ - C~6~πC~7~ - C~8~π \*18.290.280.064πC~9~ - C~4~π \*22.290.270.072C~10~ - C~11~πC~2~ - O~1~π \*27.150.300.082LP (1) N~18~--C~14~ - C~19~π \*10.090.900.086LP (1) N~12~--C~10~ - C~11~π \*45.860.300.106LP (2) O~1~--C~2~ - C~11~π \*16.220.720.100--C~2~ - O~3~π \*40.290.550.134--C~9~ - C~4~π \*32.640.340.098--C~2~ - O~1~π \*34.060.350.099[^1][^2][^3]Table 4Calculated energy gap \|∆E\| and global reactive descriptors (eV) for L~TA~ using B3LYP/6--31+*G*(d).Table 4Reactivity descriptorsFormulaL~TA~\|∆E\|\|E~LUMO~-E~HOMO~\|4.685Electronic ionization (*I*)*I*= - E~HOMO~6.541Electronic affinity (A)*A*= - E~LUMO~1.856Electronegativity (χ)*χ* = - \[E~LUMO~ + E~HOMO~\] / 24.199Chemical potentiel (µ)*µ* = \[E~LUMO~ + E~HOMO~\] / 2−4.199Chemical hardness (η)*η*=\[E~LUMO~ - E~HOMO~\]4.685Global softness (S) (eV)^−1^*S* = 1/η0.214Electrophilicity index (ω)*ω*= μ^2^ / 2η1.881Nucléophilie index (N)*N=*E*~HOMO~* - E*~HOMO~*~(~*~TCE~*~)~2.868[^4]Table 5Kinetic and computed thermodynamic parameters at temperature of 298.15 K of L~TA~ formation reaction.Table 5ParametersValuesΔH° (kcal. mol^−1^)−18.4563241ΔG° (kcal. mol^−1^)−18.7914145ΔS° (kcal. mol^−1^)0.0011255ΔG[\*](#tb5fn1){ref-type="table-fn"} (kcal. mol^−1^)59.5896046Total energy (Hartree)−915.2642448Zero-point vibrational energy (kcal. mol^−1^)166.32076Zero-point correction[\*](#tb5fn1){ref-type="table-fn"}0.265049Thermal correction to energy[\*](#tb5fn1){ref-type="table-fn"}0.284376Thermal correction to enthalpy[\*](#tb5fn1){ref-type="table-fn"}0.285320Thermal correction to Gibbs free energy[\*](#tb5fn1){ref-type="table-fn"}0.211424Sum of electronic and zero-point energies[\*](#tb5fn1){ref-type="table-fn"}−914.999196Sum of electronic and thermal energies[\*](#tb5fn1){ref-type="table-fn"}−914.979869Sum of electronic and thermal enthalpies[\*](#tb5fn1){ref-type="table-fn"}−914.978925Sum of electronic and thermal free energies[\*](#tb5fn1){ref-type="table-fn"}−915.052821Entropy, S (kcal.mol^−1^)0.155528[^5]

^1^H NMR and ^13^C NMR spectra of the ligand were recorded in deuterated DMSO solution and were reported in [Fig. 4](#fig0004){ref-type="fig"} a, b. HSQC---NMR and HMBC---NMR spectra are shown in Figs. S1a, b.Fig. 4NMR spectra of ligand: (a) ^1^H NMR and (b) ^13^C NMR.Fig 4

The theoretical and experimental chemical shifts in proton and carbon NMR of L~TA~ molecule noted δ~Cal~ and δ~Exp~, respectively, are shown in Table S5.

The chemical shift between 8.28 and 8.38 ppm in the experimental proton NMR spectrum is attributed to H12 proton bound to N12 nitrogen. The same proton presents a chemical shift of 4.83 ppm in the theoretical spectrum. The atomic charge on H12 is found to be large positive ([Fig. 2](#fig0002){ref-type="fig"}) as electronegative N atom is attached with this hydrogen. Therefore, H12 is observed on higher ppm scale [@bib0039].

The proton signals on the aromatic ring are observed in the region 7.32- 8.12 ppm and at 7.11--7.51 ppm in the experimental and theoretical spectrum, respectively. The protons on pyridine ring are seen experimentally between 7.36 and 8.76 ppm and theoretically between 7.14 and 8.49 ppm.

The junction between the cycles shows proton resonances between 4.58--4.60 ppm in the experimental spectrum and between 4.49--4.37 ppm in the theoretical spectrum.

Correlation between experimental and calculated chemical shifts of ^1^H NMR and ^13^C- NMR are given in Figs. S1 c, d. ^13^C NMR calibration plot showed a good linear relationship between the experimental and theoretical chemical shifts, with correlation coefficient R^2^=0.998.

The lower correlation coefficient (R^2^=0.80) obtained from ^1^H NMR calibration plot is due to the chemical shift of the proton at position 12 found experimentally in the range 8.28--8.38 ppm and theoretically at 4.83 ppm.

In summary, the values of the experimental and theoretical chemical shift displacements of ^1^H and ^13^C of the ligand are in agreement.

The chemical shift of all protons and carbon resonances have also been obtained based on 2D-NMR experiment.

In Heteronuclear Single Quantum Coherence (HSQC) experiment (Fig. S1a), the appearing cross-peaks correlation indicate the assignment of all protonated carbon atoms: 4.59:43.60 (H13:C13); 5.17:83.14 (H11:C11); 7.32:117.44 (H5:C5); 7.36:123.91 (H16:C16); 7.38:124.08 (H8:C8); 7.58:132.48 (H6:C6); 7.76:135.40 (H15:C15); 8.12:122.94 (H7:C7); 8.49:148.91 (H17:C17); 8.60:149.23 (H19:C19).

According to the Heteronuclear Multiple Bond Correlation (HMBC) NMR spectrum (Fig. S1b), the cross-peaks correlation provided the coupling between protons and neighboring carbons, so quaternary carbon atoms have been precisely located:

4.59:133.76:135.40:148.91:153.58 (H13:C14:C15:C17:C10); 5.17:114.87:161.85 (H11:C9 :C2); 7.32:114.87:124.08:153.50 (H5:C9:C8:C4); 7.36:133.76 (H16:C14); 7.38 :132.48:153.58 (H8 :C6 :C10); 7.58:122.94:153.50 (H6:C7:C4); 7.76:148.91:149.23 (H15:C17:C19); 8.12:132.48:153.58 (H7:C6:C10); 8.28:83.14:114.87 (H12:C11:C9); 8.60:133.76:148.91 (H19:C14:C17).

In the electron spectrum recorded in the range 200--500 nm in ethanol (Fig. S2), two peaks are observed at 210 nm and 297 nm which are attributed to π→π∗ and n→π∗ transitions of *C* = *C* and *C* = *O* groups, respectively.

The TD-DFT method \[[@bib0040], [@bib0041]\] is a reliable approach widely used to predict the spectra of electronic absorptions. The theoretical prediction of the electron absorption spectrum of L~TA~ was realized using the TD-DFT/B3LYP/6--31+*G* (d) method on optimized geometries. The calculations were carried out in ethanol solvent with PCM calculation. The calculated excitation energies, oscillator forces (f) and wavelengths (λ) are given in Table S6. The estimated UV--visible spectrum of L~TA~ is presented in Fig. S2. The strongest electronic absorption observed at 294 nm is due to HOMO-1 →LUMO (5.61%) and HOMO→LUMO (89.13%) transitions with an oscillator strength *f* = 0.14 and electronic transition energy ΔE= 4.22 eV.

3.2. Stability and electrochemical behavior of ligand L~TA~ {#sec0010}
-----------------------------------------------------------

The electrochemical behavior of the ligand was studied by cyclic voltammetry in DMSO and tetrabutylammonium hexafluorophosphate (TBAPF~6~) at a potential scan rate of 20 mV.*s* ^−^ ^1^ Platinum, glassy carbon and saturated Ag/AgCl were used as working electrode, a counter electrode and a reference electrode of platinum, respectively.

To assess the stability of the ligand, CVs were recorded up to 25 cycles at scanning rate of 20 mV/s ([Fig. 5](#fig0005){ref-type="fig"} a). The results obtained showed good reproducibility of the voltammograms, indicating the stability of this product (L~TA~) at room temperature.Fig. 5(a) Cyclic *voltammograms* (*25 cycles*) and (b) Cyclic voltammetry of ligand in DMSO and tetrabutylammonium hexafluorophosphate (TBAPF~6:~ 0.1 M), scan rate: 20 mV/s.Fig 5

The recorded voltammogram of the ligand ([Fig. 5](#fig0005){ref-type="fig"}b) gives a cathodic peak at Ep~c~=−0.56 V assigned to the reduction of *C* = *O* to OH group which in turn oxidizes at Ep~a~=−0.41 V. In the anodic part, the second peak at Ep~a~= 0.30 V is due to the oxidation of N---H to imine group (*C* = *N*) [@bib0042]. This result reveals the presence of two tautomeric forms of the ligand in solution ([Scheme 2](#fig0012){ref-type="fig"}). Scheme 2Tautomeric equilibrium of ligand (L~TA~).Scheme 2

3.3. Chemical reactivity {#sec0011}
------------------------

### 3.3.1. Orbital analysis {#sec0012}

Functional density theory (DFT) in computational chemistry is a highly dynamic tool used in several research projects to predict and determine structural properties, chemoselectivity, stereoselectivity, regioselectivity, reaction mechanisms, energy profiles and various spectroscopic characterizations.

Molecular orbitals represented by the Highest Occupied Molecular Orbital (HOMO) and Lowest Unoccupied Molecular Orbital (LUMO) are important quantum chemistry parameters. Indeed, the knowledge of the frontier orbitals allows determining the molecular properties [@bib0043].

The difference in energy between LUMO and HOMO, corresponding to energy gap (ΔE), serves to characterize the chemical reactivity and the kinetic stability of the molecule. The highest occupied molecular orbitals and lowest unoccupied molecular orbitals of the ligand have been studied and the results were given in [Fig. 6](#fig0006){ref-type="fig"} . The HOMO density plot of the stable ligand showed that the electron density is observed essentially on the 4-amino-2H-chromen-2-one ring and on the nitrogen of the pyridine ring, whereas the LUMO showed the localization of electron density just on the 4-amino-2H-chromen-2-one ring. This result predicts the localization of the electrophilic and nucleophilic attack sites of L~TA~.Fig. 6Gap energy and Frontier molecular orbitals (HOMO and LUMO) of L~TA~.Fig 6

On the other hand, we also note that the value of the energy gap of this ligand is *significant* (4.596 eV), this indicates that L~TA~ is more stable due to its hard character. This result was confirmed by the analysis of the global reactivity indices ([Section 3](#sec0005){ref-type="sec"}. [3](#sec0005){ref-type="sec"}. 5).

### 3.3.2. Molecular electrostatic potential (MEP) {#sec0013}

MEP is a very useful method to investigate the electrophilic and nucleophilic attack sites. It is directly related to the electron density, as well as hydrogen bonding interactions \[[@bib0044], [@bib0045]\]. Molecular electrostatic potential was evaluated using the B3LYP/6--31+*G*(d) method. According to [Fig. 7](#fig0007){ref-type="fig"} a, we observe different regions: those colored in red and yellow correspond to electron-rich sites (maximum negative potential), the blue region due to electron-poor sites and the green regions correspond to neutral sites (region of zero potential).Fig. 7(a) MEP surface and (b) MEP contour \[density lie within a specific range at (0010)\] of L~TA~.Fig 7

For L~TA~, the most negative regions (red and yellow) cover the carbonyl group of coumarin and the intracyclic nitrogen of 3-picolylamine. The high electronegativity of these groups (*C* = *O* and N) presents the most reactive part (the most suitable sites for electrophilic attack) of the ligand. Whereas, the blue region represents the site of highest reactivity to nucleophilic attacks.

In addition, the contour MEP is a two-dimensional (2D) representation of the areas where the relative electron density values are within a specific margin at 0010. For our compound, the contoured MEP for the positive and negative potentials is given in [Fig. 7](#fig0007){ref-type="fig"}b.

The found results allow giving information about the sites of intermolecular attacks (electrophilic and nucleophilic attacks) and the MEP map.

### 3.3.3. Natural bond order analysis (NBO) {#sec0014}

The atomic charges play an important role in the application of quantum chemical calculations to molecular systems [@bib0046] because they affect dipole moment, molecular polarizability and electronic structure [@bib0043]. Atomic charges can be used to describe the processes of electronegativity equalization and predicting the charge transfer in chemical reactions \[[@bib0047], [@bib0048]\]. The distribution of the net charges on the main L~TA~ atoms and the calculations were made using NBO theory.

The electrostatic charge values of the ligand obtained at DFT/B3LYP/6--31+*G*(d) show that O1(−0.586), O3(−0.510), N12(−0.629) and N18(−0.687) are electron-rich sites (net negative charges), while H12(0.444) is electron-poor site (net positive charges). According to this result, we conclude that the O1, O3, N12 and N18 sites are more favored for electrophilic attacks, but the H12 site is more favored for nucleophilic attacks. This result is in agreement with that found using molecular electrostatic potential (MEP).

### 3.3.4. Analysis of stabilization energies E(2) {#sec0015}

The Natural Bond Orbital (NBO) method provides information on the intramolecular and intermolecular interactions that can form within the molecule. Indeed, NBO determines the stabilization energies of a given compound using second-order perturbation theory [@bib0037]. For each donor NBO (*i*) and acceptor NBO (*j*), the stabilization energy *E*(2) associated with electron delocalization between donor and acceptor is determined as follows \[[@bib0049], [@bib0050]\]:$$E\left( 2 \right) = \Delta E_{ij} = q_{i}\frac{F\left( {i.j} \right)^{2}}{\xi_{j} - \xi_{i}}$$

With E(2) is the stabilization (delocalization) energy (kJ/mol), (ξ~j~-ξ~i~) is the difference in energy (a.u) between the donor (i) and acceptor (j) NBO orbitals, (F~i,\ j~) is the Fock matrix elements (a.u) between i and j NBO orbitals and qi is the orbital occupancy.

The results of the second-order perturbation theory of the Fock Matrix [@bib0051] are presented in [Table 3](#tbl0005){ref-type="table"}. The two largest values of energy (E(2)) are assigned to Lp(1)N12→π\*C10-C11 (45.86 kcal. mol^−1^) and Lp(2)O1→π\*C2-O3 (40.29 kcal. mol^−1^) interactions, this means that the two atoms N12 and O1 participate in the donor mesomeric relocation to stabilize the system. Other hyperactive-conjugative energy of LP(2)O1→π\*C9-C4 (32.64 kcal. mol^−1^) and LP(2)O1→π\*C2-O1 (34.06 kcal. mol^−1^) and the resonance in the aromatic ring of the 4-amino-2H-chromen-2-one fragment and in pyridine ring also plays an important role in stabilization of ligand structure.

### 3.3.5. Global indices of reactivity {#sec0016}

The global reactivity descriptors are calculated according to the Koopmans theorem [@bib0052], [@bib0053], [@bib0054], [@bib0055] by using HOMO and LUMO energy values of the geometry found by DFT calculations. These descriptors (electronic affinity (*A*), electronic ionization (*I*), chemical potential (µ), electronegativity (*X*), chemical hardness (η), softness (S), electrophilicity index (ω) and nucleophilie index (N)) are used to estimate the capacity of the molecule to exchange electrons with the external medium. These parameters are listed with formulas in [Table 4](#tbl0006){ref-type="table"}.

The global reactivity descriptors are calculated in order to confirm the nature of this crystal (electrophilic or nucleophilic). The obtained results indicate that the ligand present a hard character (chemical hardness) and the nucleophilic index value confirm that L~TA~ is more nucleophile, which promotes its complexation with biomolecules and metal ions. Therefore, the low value of chemical potential (μ), which is the additive inverse of the electronegativity (χ), may be explained by the fact that the tendency of the molecule to attract electrons is low.

The high value of ΔE indicates a higher kinetic stability of 4-\[(pyridin-3-ylmethyl) amino\]−2*H*-chromen-2-one.

3.4. Mechanism {#sec0017}
--------------

The geometries and energies of all stationary points: reagents, transition states (TS) and product (L~TA~) have been completely optimized and the vibration frequencies [@bib0056] have been calculated using B3LYP/6--31G+(d) model, implemented in Gaussian09 [@bib0057].

In order to study the kinetic and thermodynamic characteristics of the reaction mechanism of L~TA~ crystal formation given in the previous [scheme 1](#fig0011){ref-type="fig"}, calculations were performed and the results were reported in [Table 5](#tbl0007){ref-type="table"} and [Fig. 8](#fig0008){ref-type="fig"} . We note that enthalpy and free enthalpy values are very low, indicating that the reaction is moderately exothermic. In addition, the formation mechanism of L~TA~ gives a high activation enthalpy value (59.58 kcal.mol^−1^). This significant value is explained by the fact that the formation reaction of the crystal is slow at 70 °C (crystals are formed after two weeks of evaporation).Fig. 8Energetic diagram of the formation of ligand L~TA~ obtained by DFT.Fig 8

We also note that the entropy variation of this chemical reaction is positive (ΔS°=0.0011255), indicating an irreversible reaction. These results showed that the mechanism is well concerted (a single-step reaction) and the obtained product (L~TA~) is thermodynamically stable.

3.5. Thermodynamic properties of L~TA~ {#sec0018}
--------------------------------------

The thermodynamic parameters were calculated using the DFT/B3LYP/6--31+*G*(d) level at temperature of 298.15 K and in solution phase (ethanol) of L~TA~ using PCM model. The computed parameters were tabulated in [Table 5](#tbl0007){ref-type="table"}. The total energy of ligand was reported as −915.2642448 Hartrees. The sums of zero-point correction and thermal correlations to energies, enthalpies and Gibbs free energies with this calculated total energy value have been given sum of electronic and zero-point energy (−914.999196 Hartree/particle), sum of electronic and thermal energies (−914.979869 Hartree/particle), sum of electronic and thermal enthalpies (−914.978925 Hartree/particle) and sum of electronic and thermal free energies with −915.052821 Hartree/particle value. The Zero-point vibrational energy was calculated as 166.32076 kcal.mol^−1^. The calculated total value of entropy is 0.155528 kcal.mol^−1^.

3.6. Molecular docking studies {#sec0019}
------------------------------

The molecular docking of SARS-CoV-2/Mpro- L~TA~ binding mode was simulated using AutoDock Tools Vina 1.5.6. This method allows explaining of the most energetically favorable binding sites of (4-\[(pyridin-3-ylmethyl) amino\]−2*H*-chromen-2-one) to SARS-CoV-2/Mpro receptor in terms of the binding energy and inhibition constant.

The 3D Main protease (Mpro)-L~TA~ structure visualization was recorded using Discovery Studio 2020 and PyMOL software.

The aim of this study is to investigate the mode of interaction of L~TA~ with Main protease (Mpro), whose inhibition of this enzyme would prevent the virus from replication and therefore constitutes one of the potential anti-coronaviral strategies [@bib0057], which gives further clues to the prospect of developing SARS-CoV-2 drugs. Target protein (SARS-CoV-2/Mpro: [Fig. 9](#fig0009){ref-type="fig"} a and Table S8) was retrieved from the Protein Data Bank (PDB: 6Y84) [@bib0058].Fig. 9The representative structure of SARS-CoV-2/Mpro- L~TA~ complex: (a) SARS-CoV-2/Mpro is represented in Ribbon drawings, L~TA~ and binding sites are represented in stick and in color (red and blue), respectively; (b) 2D diagram of the interaction of L~TA~ with SARS-CoV-2/Mpro from AutoDock Tools Vina 1.5.6. docking.Fig 9

The interactions of (4-\[(pyridin-3-ylmethyl) amino\]−2*H*-chromen-2-one) with the protein are described in detail in [Figs. 9](#fig0009){ref-type="fig"} and [10](#fig0010){ref-type="fig"} . Indeed, the ligand (L~TA~) binds with SARS-CoV-2/Mpro via multiple hydrogen and Van der Waals bonding contacts, pi-pi T-shaped, carbon hydrogen and alkyl bonds, and also via hydrophobic contacts. Asn 142 form intermolecular conventional H-bond with L~TA~, while His 163, Cys 145 and Met 165 form carbon hydrogen and pi-donor hydrogen bond, respectively. Whereas, Cys 44, Ser 46, Leu 141, Phe 140, Ser 44, His 172, Glu 166, Gly 143, Thr 26, Leu 27 and Thr 25 form Van der Waals interactions with inhibitor ligand. In addition, Met 49 and Cys 145 give pi-alkyl bonds and His 41 gives pi-pi T-shaped bond with L~TA~ ([Fig. 9](#fig0009){ref-type="fig"}b).Fig. 10Docking studies of L~TA~ binding-active site of SARS-CoV-2/Mpro with various bonding interactions. (a) H-bond; (b) Hydrogen bonds (colored dashed lines, distances are in Å units) between SARS-CoV-2/Mpro and the inhibitor (ligand); (c) Interpolated charge; (d) Aromatic; (e) Hydrophobic and (f) Ionizability distributions.Fig 10

[Fig. 10](#fig0010){ref-type="fig"}a reports 3D-illustration of the H-bond interactions between the inhibitor (L~TA~) and the amino acids of SARS-CoV-2/Mpro. The region occupied by Asn 142 is electron acceptors (in green) and these occupied by other amino acids are electron donors (in purple).

[Fig. 10](#fig0010){ref-type="fig"}b shows that the oxygen and sulfur of the *C* = *O* and S-H groups of the amino acids (Asn 142 and Cys 145) are in close proximity 2.12 Å (conventional H-bond) and 4.41 Å (pi-donor H-bond) to L~TA~. The aromatic ring of the ligand is in close to His 41 with the distance of 4.28 Å and forms pi-pi T-shaped interaction.

The interpolated charge (electrostatic charge) contour map ([Fig. 10](#fig0010){ref-type="fig"}c) shows significant increase of negative charge in the red contour region, leading to increased activity with L~TA~.

The SARS-CoV-2/Mpro also displayed few hydrophobic contacts mediated by the aliphatic amino acids ([Fig. 10](#fig0010){ref-type="fig"}e), and it is moderately basic (in blue) ([Fig. 10](#fig0010){ref-type="fig"}f).

The 3D structure visualizations ([Fig. 10](#fig0010){ref-type="fig"}a, b-f) showed that SARS-CoV-2/Mpro envelopes the ligand, this creates a strong cohesive environment and stability of the formed complex. The enclosed SARS-CoV-2/Mpro-L~TA~ complex should be inactive against cells in the human body.

Through docking simulation, various physical parameters were obtained. The binding energy calculated for L~TA~- SARS-CoV-2/Mpro complex (−7.03 kcal. mol^−1^), intermolecular energy (−7.93 kcal. mol^−1^), Van der Waals/H-bond/desolvation energy (−7.89 kcal. mol^−1^) and inhibition constant (6.98 μM) show active L~TA~ molecule with the ability to inhibit SARS-CoV-2. This high binding affinity is as linked with the presence of four H-bonds with the amino acids Asn 142, His 163, Met 165 and Cys 145.

In summary, the binding mode demonstrated in this study therefore provides a useful clue to understanding the possible molecular basis and interaction of this inhibitor (L~TA~) with SARS-CoV-2.

Comparing the results found in this work with those reported in the literature, we find that both molecules chloroquine and hydroxychloroquine present lower binding energy (chloroquine: −5.9 kcal. mol^−1^; hydroxychloroquine: −6.0 kcal. mol^−1^) and inhibition constants (chloroquine: 30.8 μM; hydroxychloroquine: 22.9 μM) [@bib0027].

4. Conclusion {#sec0020}
=============

In the present work, synthesis, spectroscopic characterization (ATR, NMR and UV-Visible), crystal structure of 4-\[(*pyridin*-3-*ylmethyl*) *amino*\]−2*H*-chromen-2-one (L~TA~) were reported. Density functional theory (DFT) has been applied to support the experimental results and to report the various molecular properties like HOMO-LUMO energies and gap, NBO and MEP properties, global reactivity descriptors, kinetic and thermodynamic parameters of L~TA~. In addition, molecular docking was used to investigate the mode of interaction of L~TA~ with SARS-CoV-2/Mpro.

The results of single crystal X-ray diffraction analysis show that this compound crystallized in monoclinic system with space group P 2~1~ (*Z* = 4).

The natural bond order (NBO) analysis and the molecular MEP map showed that the O1, O3, N12 and N18 sites are more favored for electrophilic attacks, but the H12 site is more favored for nucleophilic attacks. The stabilization energy E(2) showed that N12 and O1 participate to stabilize L~TA~. The global reactivity descriptors obtained indicate that the ligand is more nucleophile and presents a hard character.

The kinetic and thermodynamic parameters of L~TA~ showed that the formation mechanism of the crystal is moderately exothermic with a high activation enthalpy. These results indicate that the synthetic product (L~TA~) is thermodynamically stable.

The interaction of (4-\[(pyridin-3-ylmethyl) amino\]−2*H*-chromen-2-one) with SARS-CoV-2/Mpro revealed that the ligand (L~TA~) binds to SARS-CoV-2/Mpro via multiple bonding contacts. Through docking simulation, the binding energy calculated for SARS-CoV-2/Mpro- L~TA~ complex and inhibition constant showed active L~TA~ molecule with the ability to inhibit SARS-CoV-2 (Covid-19).
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[^1]: E(2): Stabilization (delocalization) energy (kJ/mol).

[^2]: (ξ~j~-ξ~i~): Energy difference (a.u) between donor (i) an acceptor (j) NBO orbitals.

[^3]: (F~i,\ j~): Fock matrix elements (a.u) between i and j NBO orbitals.

[^4]: *TCE* : Tetra Cyano Ethylene.

[^5]: in Hartree/particle.
